COMMUNIQUÉS West-GlobeNewswire

IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170
25/04/2025
Preclinical data further support the potential of dual-antigen and TGF-β-directed vaccines to reshape the tumor microenvironment and drive anti-tumor immunity NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- IO Biotech ( [...]
Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
25/04/2025
BDC-3042 was well tolerated up to 10 mg/kg q2w with no dose-limiting toxicities and no drug-related serious adverse events BDC-3042 showed biological activity, with clear dose-dependent increases in proinflammatory [...]
Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets
25/04/2025
Nurix's lead BTK degrader, bexobrutideg, demonstrates exceptional efficiency, with a single molecule degrading approximately 10,000 copies of BTK per hour BRAF degrader demonstrates broad activity across all three BRAF [...]
Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025
25/04/2025
CINCINNATI, April 25, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® wearable drug delivery platform, announced today the [...]
Best SARMs for Bulking, Cutting, Fat Loss & Muscle Growth: Top Selective Androgen Receptor Modulators Reviewed for Lean Gains & Shredded Physique From CrazyBulk
25/04/2025
Discover the best SARMs for bulking, cutting, fat loss, and muscle growth in 2025. Boost strength, shred fat, and enhance performance naturally with powerful, legal SARMs alternatives. New York City, April 25, 2025 ( [...]
Juvent Launches Next Generation Bone Health Supplement HydroxyBMD3 at the National Bone Health & Osteoporosis Foundation (BHOF) Symposium in Washington, DC
25/04/2025
OOLTEWAH, Tenn., April 25, 2025 (GLOBE NEWSWIRE) -- Juvent, an innovator in clinically validated bone and musculoskeletal health solutions, debuted its revolutionary new supplement system HydroxyBMD 3 at the National [...]
Parliament Gets Paw-litical: Voting Open for Cutest Pets on Parliament Hill Photo Contest
25/04/2025
OTTAWA, April 25, 2025 (GLOBE NEWSWIRE) -- The Canadian Animal Health Institute (CAHI) is thrilled to announce that public voting is now open for the 3rd Annual Cutest Pets on Parliament Hill photo contest! Canadians [...]
Le Parlement est en pleine campagne « poil » itique : Le vote est ouvert pour le concours photo « Les animaux de compagnie les plus mignons sur la Colline du Parlement »
25/04/2025
OTTAWA, 25 avr. 2025 (GLOBE NEWSWIRE) -- L’Institut canadien de la santé animale (ICSA) est ravi d’annoncer que le vote du public est maintenant ouvert pour le 3e concours annuel de photos « Les animaux les plus mignons [...]
Press release: Transparency Notification from Shareholders
25/04/2025
Transparency Notification from Shareholders Ghent, Belgium – 25 April 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of drug-resistant fluid [...]
My Grief Angels Inc Launches Mother's Day "Bouquet of Support" for Grieving Moms
25/04/2025
A Compassionate Mother's Day Initiative for Mothers Grieving THE WOODLANDS, Texas, April 25, 2025 (GLOBE NEWSWIRE) -- As Mother's Day approaches, My Grief Angels Inc, a renowned 501(c)(3) public charity, is extending a [...]
Mental Health Nonprofit Queer LifeSpace to Host Annual Fundraising Gala "Pride Renaissance: Celebrating Community Resilience"
25/04/2025
Biggest fundraising gala in organization’s history aims to raise $75,000 for accessible, queer-affirming mental health care SAN FRANCISCO, April 25, 2025 (GLOBE NEWSWIRE) -- In the midst of a worsening mental health [...]
2024 Annual Report Vistin Pharma ASA
25/04/2025
Oslo, Norway, 25 April 2025 Please find attached the Annual Report for 2024 for Vistin Pharma ASA (VISTN). There are no material changes in the financial statements compared to the preliminary full year results [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
25/04/2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 25 April 2025 at 17.20 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
CHMP recommends EU approval for Duvyzat to treat Duchenne muscular dystrophy
25/04/2025
Recommendation is based on Phase 3 EPIDYS trial data that demonstrated Duvyzat (givinostat) provides statistically and clinically meaningful treatment benefits in individuals with Duchenne muscular dystrophy (DMD) If [...]
Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025
25/04/2025
BEDFORD, Mass., April 25, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its first quarter [...]
InspireMD to Announce First Quarter 2025 Financial Results
25/04/2025
MIAMI, April 25, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease (CAD) and prevention of stroke, today announced [...]
Altamira Therapeutics to Host Full Year 2024 Financial Results and Business Update Call on April 30, 2025
25/04/2025
Hamilton, Bermuda, April 25, 2025 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB: CYTOF), a company dedicated to developing and commercializing RNA delivery technology for targets [...]
Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division
25/04/2025
DALLAS, TX, April 25, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals Inc. (NASDAQ: MGRX) (“ Mangoceuticals ” or “ MGRX ”), a company focused on developing, marketing, and selling a variety of health and wellness products via a [...]
ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints
25/04/2025
In ASPEN-03 and ASPEN-04 trials, efficacy data do not support advancing evorpacept in combination with Merck’s anti-PD-1 therapy, KEYTRUDA ® (pembrolizumab), into a registrational study Company remains confident in [...]

Pages